Company Registration Number 09446657 (England and Wales)
BERNARD PRENDERGAST CARDIOLOGY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
PAGES FOR FILING WITH REGISTRAR
BERNARD PRENDERGAST CARDIOLOGY LIMITED
BALANCE SHEET
AS AT
31 MARCH 2023
31 March 2023
- 1 -
2023
2022
£
£
£
£
Fixed assets
34,866
5,655
Current assets
61,188
97,651
Creditors: amounts falling due within one year
(5,363)
(3,652)
Net current assets
55,825
93,999
Total assets less current liabilities
90,691
99,654
Accruals and deferred income
(2,076)
(1,926)
Net assets
88,615
97,728
Capital and reserves
88,615
97,728
Notes to the financial statements
1
Directors' benefits: advances, credit and guarantees
During the year a director withdrew funds from the company totalling £8,016 (2022: £5,033). The directors introduced funds totalling £5,040 (2022: £5,040). At the balance sheet date £10,329 (2022: £7,180) remains due to the company and is include with other debtors.
Interest of £173 (2022: £NIL) has been charged on amounts due from the director at the official HMRC rate of interest.
2
Employees
The average number of persons, including directors, employed by the company during the year was as follows:
2023
2022
Number
Number
Employees
2
2
Bernard Prendergast Cardiology Limited is a private company limited by shares incorporated in England and Wales. The registered office is Flat 2, 67 Sutherland Street, London, SW1V 4JY.
For the year ended 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
BERNARD PRENDERGAST CARDIOLOGY LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2023
31 March 2023
- 2 -
These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 29 February 2024 and are signed on its behalf by:
..............................................
Dr B D Prendergast
Director
Company registration number 09446657 (England and Wales)